Contact Us: 01282 426380
KM Financial Solutions | Oxford/AstraZeneca study supports UK decision to delay second doses
83415
post-template-default,single,single-post,postid-83415,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

Oxford/AstraZeneca study supports UK decision to delay second doses

01 Feb Oxford/AstraZeneca study supports UK decision to delay second doses

Posted at 19:08h in News by
0 Likes
New Oxford analysis, not yet peer-reviewed, shows single jab to be 76% effective for up to 12 weeks
No Comments

Sorry, the comment form is closed at this time.